Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 472306151 series 1548333
Content provided by Congress of Neurological Surgeons Podcasts and Congress of Neurological Surgeons. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Congress of Neurological Surgeons Podcasts and Congress of Neurological Surgeons or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Patients with metastatic brain tumors (MBTs) require a multidisciplinary team-based approach to select the best treatment interventions. This podcast updates recommendations that address whether treatment with immune modulators benefits patients with parenchymal or leptomeningeal brain metastases in terms of local control, OS, PFS, performance status, or reduction in CNS side effects compared with standard management with chemotherapy, molecular targeted agents, SRS, WBRT, and surgical resection. J. Bradley Elder, MD Jeffrey J. Olson, MD D. Ryan Ormond, MD, Phd
…
continue reading
178 episodes
))
